Venous thromboembolism (VTE) is a chronic disease. Recurrence can be prevented by
anticoagulants, albeit at the cost of bleeding. Assessing the risk of recurrence is important to …

Background It is unclear whether thrombophilia testing provides any further information on
risk of recurrence or guidance in management of patients with a first episode of idiopathic …

Background Thrombophilia testing has limited value in determining the selection and
duration of anticoagulation therapy for venous thromboembolism (VTE), yet is commonly …

Venous thromboembolism (VTE), which encompasses deep vein thrombosis (DVT) and
pulmonary embolism (PE), is a significant cause of morbidity and mortality worldwide. There …

BACKGROUND: There is scarce information on the management habits with regard to
thrombophilia testing in patients with venous thromboembolism (VTE). PATIENTS AND …

Management of venous thromboembolism (VTE) includes evaluation for hypercoagulable
state, especially if the VTE occurs in young patients, is recurrent, or is associated with a …

Thrombophilia can be identified in about half of all patients presenting with venous
thromboembolism (VTE). Thrombophilia screening for various indications has increased …

Background: Whether screening for thrombophilia is useful for patients after a first episode of
venous thromboembolism (VTE) is a controversial issue. However, the impact of …

Objectives The aim of this work is to tempt to define the best indications for thrombophilia
testing in VTE in clinical practice. On behalf of the French Group for Haemostasis and …

In the last ten years, several risk factors that increase the risk of venous thrombosis have
been discovered. Venous thrombosis is a multicausal disease in which several risk factors …